Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jones Lang LaSalle Inc (JLL) vs Eli Lilly And Co (LLY) Price & Performance

Jones Lang LaSalle IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Jones Lang LaSalle Inc vs Eli Lilly And Co — how do they compare? Jones Lang LaSalle Inc trades at $361.02 (market cap $16.72B), while Eli Lilly And Co trades at $1,214.24 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 64.6× Jones Lang LaSalle Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.

JLLLLY
Market Cap
$16.72B$1.08T
Sector
Real EstateHealth
52-Week High
$373.24$1.24K
52-Week Low
$280.16$639.43
Enterprise Value
$19.48B$1.13T
Dividend Yield
0.57%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Jones Lang LaSalle Inc

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.

Read more on JLL

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY